CONSUN PHARMA (01681) spent HKD 1.9573 million to repurchase 13.1 thousand shares on November 26th.
Kangson Pharmaceutical (01681) announced that on November 26, 2025, the company spent HKD 1,957,300 to repurchase 13,100 shares at a repurchase price of HKD 14.92-14.97 per share.
CONSUN PHARMA (01681) announced on November 26, 2025, that the company will spend 1.9573 million Hong Kong dollars to repurchase 13,100 shares, with a repurchase price per share ranging from 14.92 to 14.97 Hong Kong dollars.
Related Articles

BRIGHT SMART (01428) announces its interim financial results, with a net profit of HK$327 million, a year-on-year increase of 4.77%.
.png)
SUPER HI (09658) releases its third-quarter results, with a shareholder net profit of 3.609 million US dollars, a year-on-year decrease of 90.43%.

Jilin Oled Material Tech (688378.SH) plans to raise no more than 300 million yuan through private placement.
BRIGHT SMART (01428) announces its interim financial results, with a net profit of HK$327 million, a year-on-year increase of 4.77%.

SUPER HI (09658) releases its third-quarter results, with a shareholder net profit of 3.609 million US dollars, a year-on-year decrease of 90.43%.
.png)
Jilin Oled Material Tech (688378.SH) plans to raise no more than 300 million yuan through private placement.

RECOMMEND

Foreign Brands “Take On Chinese Names”: Starbucks And Burger King Change Hands As Chinese Capital’s Localization Scalpel Rewrites Global Rules
25/11/2025

Riding The Momentum Of Gemini 3, “Google Chain” Challenges “Nvidia Chain,” Reshaping The Ai Trading Landscape
25/11/2025

Silver Economy Accelerates As Personal Pension System Marks Three Years — Structural Changes Emerging
25/11/2025


